期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
白血病阶段的小细胞亚型间变性大细胞淋巴瘤1例并文献复习
1
作者 杨菁 张永红 《中国小儿血液与肿瘤杂志》 CAS 2016年第2期87-91,共5页
目的探讨间变性大细胞淋巴瘤(ALCL)白血病阶段的临床特点、诊断、治疗及相关进展。方法对一例白血病阶段的ALK阳性的ALCL患者的诊治经过进行回顾性分析及相关文献复习。结果4岁男童因淋巴结肿大24d入院,院外按淋巴结炎抗感染治疗无... 目的探讨间变性大细胞淋巴瘤(ALCL)白血病阶段的临床特点、诊断、治疗及相关进展。方法对一例白血病阶段的ALK阳性的ALCL患者的诊治经过进行回顾性分析及相关文献复习。结果4岁男童因淋巴结肿大24d入院,院外按淋巴结炎抗感染治疗无效。入院时患儿高热,精神差,肝、脾、淋巴结肿大,白细胞81.99×10^9/L。根据病理、FISH、骨髓流式细胞术、细胞因子检查确诊为小细胞型ALCL的白血病阶段,合并高细胞因子血症。给予血浆置换使患者一般状态得到改善后立即给予化疗,期间合并骨髓抑制及感染,家长放弃治疗。结论小细胞病理亚型的ALCL侵袭性强,可以合并白血病,易和感染性疾病及其他小细胞肿瘤相混淆,需引起临床医生的注意。患者可合并高细胞因子血症,致病情危重,治疗风险大。 展开更多
关键词 间变性大细胞淋巴瘤 小细胞亚型 白血病 预后
下载PDF
IP-10 and fractalkine induce cytotoxic phenotype of murine NK cells
2
作者 Fang Liu Junfang Qin +4 位作者 Hongyao Zhang Ning Li Meihua Shan Lan Lan Yue Wang 《Science Bulletin》 SCIE EI CAS CSCD 2016年第3期202-211,共10页
We characterized the murine NK cell subsets of the tumor microenvironment (TME) with low expressions of CD16 and NKG2D and investigated the chemokines that deter CD 16~~w NKG2Dl^w subsets. Our results demonstrated t... We characterized the murine NK cell subsets of the tumor microenvironment (TME) with low expressions of CD16 and NKG2D and investigated the chemokines that deter CD 16~~w NKG2Dl^w subsets. Our results demonstrated the activation of primary and KY- 1 NK cell by ligands and found that exogenous CXCL10/interferon-gamma-induced protein 10 (IP-10) and fractalkine (FKN) can up-regulate the expression of CD 16 and NKG2D. Moreover, both IP-10 and FKN are shown to facilitate migration, adhesion and cyto- toxicity of NK cell subsets of the TME, due to the up-regu- lated CD16 and NKG2D. Overall, our data provide a new path by which to enhance murine NK cell cytotoxic potential and improve the quality of NK cells of the TME. 展开更多
关键词 CHEMOKINES NK cell Activating receptors Tumor microenvironment
原文传递
Identification of a new isoform of the murine Sh2d1a gene and its functional implications 被引量:2
3
作者 WU LongYan LU PeiWen +3 位作者 MA WeiWei CHU CoCo XU HePing QI Hai 《Science China(Life Sciences)》 SCIE CAS 2014年第1期81-87,共7页
Signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) is a Src homology (SH) domain 2-containing in- tracellular adaptor protein that is predominantly expressed in the hematopoietic system by... Signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) is a Src homology (SH) domain 2-containing in- tracellular adaptor protein that is predominantly expressed in the hematopoietic system by T lymphocytes and NK cells. SAP protein is encoded by the SH2DIA gene located on the X chromosome. Loss-of-function mutations in SAP cause the X-linked lymphoproliferative disease (XLP), a severe immunodeficiency characterized by heightened susceptibility to Epstein-Barr vi- rus and impaired humoral immunity. Normal individuals express several functional and non-functional isoforms of SAP as a result of alternative splicing. In this study, we identify a cryptic exon in the murine Sh2dla gene. At the mRNA level, the new isoform of SAP (SAP-2) that includes this new exon is widely expressed in lymphoid tissues by C57BL/6 and 129 strains of inbred mice. SAP-2 accounts for approximately 1%-3% of total SAP transcripts, and it is dynamically regulated during lym- phocyte activation. At the protein level, the SAP-2 isoform is a 144 amino-acid protein. Compared to the dominant 126 ami- no-acid SAP-I isoform, the additional 18 amino acids are inserted into a structural region that is critical for phosphotyrosine binding. Our functional analysis in vitro indicates that SAP-2 is a non-functional isoform due to decreased protein stability. Thus, both human and mouse have multiple SAP splice isoforms that may or may not function. Modulation of relative propor- tions of these isoforms is potentially a mechanism whereby cells can regulate SAP-mediated biological activities. 展开更多
关键词 Sh2dla SAP X-linked lymphoproliferative disease (XLP) ISOFORM
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部